Oncology
Enhancing Oncology Care for Breast and Lung Cancer Patients in the Kingdom of Saudi Arabia
The objective of this program is to help educate and support pharmacists in the Kingdom of Saudi Arabia in understanding the current landscape of approved therapies for breast cancer and lung cancer, with a focus on targeted therapy and immunotherapy. The program also describes how pharmacists can collaborate within a multidisciplinary team to support patients throughout their oncology journey, from diagnosis through treatment and follow-up.
DURATION
1 hr
PROFESSION
Pharmacy
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2024-07-26
The incidence of both breast cancer and lung cancer is rising in the Kingdom of Saudi Arabia (KSA). An aging population and a growing popularity of smoking are contributing factors to the predicted increase in the number of cases of both these types of cancer. Pharmacists can play a role in patient education to contribute to efforts to prevent lung and breast cancer.
Many different treatment approaches exist for both breast and lung cancer. The objective of this program is to help educate and support pharmacists in the Kingdom of Saudi Arabia in understanding the current landscape of approved therapies for breast cancer and lung cancer, with a focus on targeted therapy and immunotherapy. The program also describes how pharmacists can collaborate within a multidisciplinary team to support patients throughout their oncology journey, from diagnosis through treatment and follow-up.
This program is supported by Novartis.
Faculty
Majed Alshamrani, PharmD, MBA, BCPS
Meteb Al-Foheidi, MD
Nora A. Alkhudair, Assistant Professor, PharmD
Hamed Alhussaini, MD
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- List the risk factors for breast cancer and identify patients who are at high risk.
- Describe the role of targeted therapy (i.e., CDK inhibitors) in breast cancer treatment.
- Discuss the role of targeted therapy and immunotherapy in the treatment of lung cancer.
- Describe the recommendations for the management of lung cancer per the Saudi Lung Cancer Management Guidelines.
- Collaborate within a multidisciplinary team throughout a patient’s oncology journey, from diagnosis through treatment and follow-up.